THIS WEBSITE IS INTENDED FOR U.S. RESIDENTS ONLY |For Healthcare Professionals

Savings Copay Card

Please complete the form below to receive your patient savings copay card. You may qualify to save on your prescription of SUTAB with this coupon.

Terms and conditions apply, see below for more details.

Sutab_Copay$40_printCARD

*Indicates a required field.

To Patient: Present this card to your pharmacy along with a valid prescription for SUTAB®. Commercially insured patients will receive savings up to the program maximum after paying the ­first $40. Cash patients will receive savings up to the program maximum after paying the ­first $75. Any additional amounts due are your responsibility. This offer is limited to one use and is not transferable. By using this card, you acknowledge that you meet the eligibility criteria and will comply with the terms and conditions. If you have any questions, call 1-844-926-4140.

Pharmacist Instructions for Commercially Insured Patient: Submit the claim to the primary Third Party Payer ­first, then submit the balance due to Change Healthcare as a Secondary Payer COB with patient responsibility amount and a valid Other Coverage Code (e.g. 8, 3). The patient is responsible for the ­first $40.00 and reimbursement for the balance, up to the program maximum, will be received from Change Healthcare.

Pharmacist Instructions for a Cash Paying Patient: Submit this claim to Change Healthcare. A valid Other Coverage Code (e.g. 0, 1) is required. The patient is responsible for the ­first $75.00 and reimbursement for the balance, up to the program maximum, will be received from Change Healthcare.

IMPORTANT SAFETY INFORMATION

INDICATION
SUTAB® (sodium sulfate, magnesium sulfate, potassium chloride) tablets for oral use is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

DOSAGE AND ADMINISTRATION
A low residue breakfast may be consumed. After breakfast, only clear liquids may be consumed until after the colonoscopy. Administration of two doses of SUTAB (24 tablets) are required for a complete preparation for colonoscopy. Twelve (12) tablets are equivalent to one dose. Water must be consumed with each dose of SUTAB and additional water must be consumed after each dose. Complete all SUTAB tablets and required water at least 2 hours before colonoscopy.

CONTRAINDICATIONS
Use is contraindicated in the following conditions: gastrointestinal obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, gastric retention.

WARNINGS AND PRECAUTIONS
Risk of fluid and electrolyte abnormalities: Encourage adequate hydration, assess concurrent medications and consider laboratory assessments prior to and after each use. Cardiac arrhythmias: Consider pre-dose and post-colonoscopy ECGs in patients at increased risk. Seizures: Use caution in patients with a history of seizures and patients at increased risk of seizures, including medications that lower the seizure threshold. Patients with renal impairment or taking concomitant medications that affect renal function: Use caution, ensure adequate hydration and consider laboratory testing. Suspected GI obstruction or perforation: Rule out the diagnosis before administration.

ADVERSE REACTIONS
Most common gastrointestinal adverse reactions are nausea, abdominal distension, vomiting, and upper abdominal pain.

DRUG INTERACTIONS
Drugs that increase risk of fluid and electrolyte imbalance.

View the Full Prescribing Information and Medication Guide.

References: 1. Di Palma JA, Bhandari R, Cleveland M, et al. A safety and efficacy comparison of a new sulfate-based tablet bowel preparation versus a PEG and ascorbate comparator in adult subjects undergoing colonoscopy. Am J Gastroenterol. Published online November 6, 2020. doi: 10.14309/ajg.0000000000001020. 2. SUTAB® [package Insert]. Braintree, MA: Braintree Laboratories, Inc; 2020. 3. IQVIA. National Prescription Audit Report. November 2020. 4. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 (corrected). Am J Gastroenterol. 2009;104(3):739-750.